HC Wainwright & Co. Reiterates Buy on Bionomics, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Bionomics (NASDAQ:BNOX) and maintained an $8 price target for the company's stock.
December 07, 2023 | 11:38 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst reaffirms a Buy rating and an $8 price target on Bionomics, indicating a positive outlook for the stock.
The reiteration of a Buy rating and maintenance of the price target by a reputable analyst like Joseph Pantginis could lead to increased investor confidence in Bionomics, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100